Skip to main content
  • Meeting abstract
  • Published:

Effects of stress-dose hydrocortisone therapy in septic shock (part III): monocyte HLA-DR expression and blood interferon-? concentration. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study

Background

Immunoparalysis, defined as a decreased level of human Ieukocyte antigen (HLA)-DR receptor expression on monocytes, correlates with the severity of septic shock and outcome [1].

Hydrocortisone (HC) alters the immune response at almost all levels and is considered to suppress HLA-DR expression on monocytes. IFN-? as a potent activator of mononuclear phagocytes increases the ability of monocytes to express HLA-DR in vitro and in vivo. One of the aims of our study was to analyzeimmunosuppressive effects of HC stress-dose therapy in septic shock patients. Here we present results of an interim analysis of the first 20 patients enrolled in the study.

Methods

The study was designed as a double blinded, randomized, cross-over, placebo-controlled trial in 40 patients. Patients who fulfilled the criteria for septic shock according to the Consensus Conference on Sepsis and Organ Failure [2] received a dose of 10 mg/h hydrocortisone after an initial loading dose of 100 mg, or placebo for 3 days. After 3 days, patients from the HC-group switched to the placebo-group and vice versa. Blood samples were obtained before the study and daily for a period of 6 days. A whole blood flow-cytometry analysis was performed to analyze monocyte HLA-DR antigen expression. Plasma IFN-? levels were measured by an enzyme-linked immunoassay.

Results

There were no striking differences in monocyte HLA-DR expression between patients who received HC or placebo (Fig. 1). However, compared to baseline values, a transient decrease of HI.A-DR expression was observed in the group which received HC early. INF-? increased in both groups after start of the study, but returned to baseline in the placebo-group on day 3 (Fig. 2). In the follow-up, INF-? did not further increase in the placebo-group but noticeably in the HC-group.

Conclusion

Stress-dose HC treatment did not induce immunoparalysis in patients with septic shock during the study period. HLA-DR expression remained almost constant over the period of the trial which we postulate to be due to HC-induced increase of INF-? synthesis.

Figures 1-2.
figure 1

Monocyte HLA-DR expression (Fig. 1) and IFN-gamma concentration (Fig. 2) in septic shock patients who received hydrocortisone therapy (see text). Day 0: before study. Data are presented as mean-values with SEM; n = 10 for each data point.

References

  1. Hershman MJ, et al: . Injury. 19: 263-266. 10.1016/0020-1383(88)90042-3.

  2. Bone RC, et al: . Crit Care Med. 1992, 20: 864-874.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böhnke, T., Schulz, C., Keh, D. et al. Effects of stress-dose hydrocortisone therapy in septic shock (part III): monocyte HLA-DR expression and blood interferon-? concentration. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study . Crit Care 3 (Suppl 1), P106 (2000). https://doi.org/10.1186/cc480

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc480

Keywords